Skip to main content
Clinical Trials/NCT00821119
NCT00821119CompletedNot Applicable

A Randomized Controlled Trial of Nasal Intermittent Positive Pressure Ventilation Versus Nasal Continuous Positive Pressure as a Primary Mode for Respiratory Distress Syndrome in Preterm Infants

Instituto Materno Infantil Prof. Fernando Figueira3 sites in 1 country200 target enrollmentStarted: August 1, 2007Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
200
Locations
3
Primary Endpoint
Mechanical Ventilation Within the First 72h of Life in the Two Study Groups.(NIPPV vs NCPAP)

Study Overview

Brief Summary

The purpose of this study is to evaluate the hypothesis that nasal intermittent positive pressure(NIPP), used as a primary mode of ventilation in preterm infants with RDS, will decrease the need for conventional endotracheal ventilation when compared to nasal continuous positive airway pressure.(NCPAP)

Detailed Description

Respiratory distress syndrome(RDS) and its sequelae, bronchopulmonary dysplasia(BPD) are complications of prematurity.The pathogenesis of BPD is multifactorial and one of the most important risk factors is the ventilator-induced lung injury caused by invasive respiratory support.

The two modes of non-invasive ventilation, NIPP and specially NCPAP, have been used frequently in the respiratory care of preterm infants in neonatal units.NCPAP is currently a common practice for the treatment of RDS . NIPP has been found to be more effective than NCPAP in apnea of prematurity and immediately after extubation in preterm infants,decreasing the need of endotracheal ventilation.

Alternative techniques of non-invasive ventilation has been suggested in some studies to decrease respiratory morbidities associated with prematurity.This non-invasive approach could be used initially as a primary mode of ventilation for infants with RDS in a effort to decrease lung injury and BPD.Studies are needed to compare the effectiveness of these therapies.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
1 Day to 1 Day (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • preterm infants with RDS
  • assigned to non invasive ventilation

Exclusion Criteria

  • preterm on endotracheal ventilation
  • severe congenital pulmonary or cardiovascular malformation

Outcomes

Primary Outcomes

Mechanical Ventilation Within the First 72h of Life in the Two Study Groups.(NIPPV vs NCPAP)

Time Frame: first 3 days of life(72hours)

The primary outcome of the study was the need for intubation within the first 72 hours (h) of life.The need for intubation was made by the attending neonatologist, according to the strict protocol of intubation for ventilation, used in the neonatal Unit

Need for Endotracheal Ventilation in the First 72 hs of Life

Time Frame: first 72 hs of life

number of participants that needed endotracheal ventilation (failed non invasive ventilation) in the first 72 hours of life

Secondary Outcomes

  • Bronchopulmonary Dysplasia(at 36 weeks gestational age)

Investigators

Sponsor
Instituto Materno Infantil Prof. Fernando Figueira
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jucille do Amaral Meneses

Jucille Meneses Md PhD

Instituto Materno Infantil Prof. Fernando Figueira

Study Sites (3)

Loading locations...

Similar Trials

Completed
Not Applicable
Effectiveness of nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure in preterm infants after less invasive surfactant administratioForty one received nIPPV as an initial RS. If nIPPV failed&#44surfactant administration was given with the LISA approach and patients continued on nIPPV. This group was compared with a historical cohortNasal intermittent positive pressure ventilationnasal continuous positive airway pressurerespiratory distress syndromepreterm infantless invasive surfactant administration
TCTR20180905004Sohag University, Egypt41
Completed
Not Applicable
Nasal Intermittent Positive Pressure Ventilation In Newborn Infants With Respiratory Distress SyndromeRespiratory Distress Syndrome
NCT00780624Third Military Medical University100
Completed
Not Applicable
Nasal Intermittent Positive Pressure Ventilation During Neonatal IntubationRespiratory Distress SyndromeNewborn MorbidityDesaturation of BloodVentilator Lung NewbornDifficult or Failed Intubation
NCT06549283Muğla Sıtkı Koçman University146
Terminated
Phase 2
A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive DisorderObsessive-Compulsive Disorder
NCT02234011Mclean Hospital1
Completed
Not Applicable
A randomised controlled trial of nasal constant positive airway pressure (NCPAP) as primary therapy for respiratory distress syndrome (RDS) in very pre-term infants.eonatal Diseases: RespiratoryNeonatal DiseasesRespiratory
ISRCTN68552342Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)200